Skip to main content

ZEPP · Zepp Health Corp

Track ZEPP — free
$2.32 +0.10 (+4.28%)
Market Cap
$32.56M
Shares
14.66M
Volume · Nov 4 42.88K Avg daily vol (3M) 48.78K

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$2.22 Open$2.22 Day$2.20–2.35 52W close$2.20–38.90 Avg vol 30d52K Short int335K · 2.3% of shares · 16.5d Short vol53% Last earningsSep 2, 2026 DataJan 2020–Nov 2026

Up next

Nov 21, 2026 Est · unconfirmed · in 2 wks

Latest documents

2026
Apr 24
Annual report 20-F FY2025, ended Dec 31
Annual report for FY2025 AI summary on its way
Revenue $258.9M ▲ 41.8% Net loss $40.07M Diluted EPS -$0.16
All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$276.03M
Trailing 12 months
Net income (TTM)
−$43.56M
Trailing 12 months
Revenue growth YoY
+6.9%
Year over year
Operating margin
-12.6%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
−$175.25M
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
-0.1%
Year over year · fewer shares
Price change (1Y)
-94.5%
Trailing year
Short interest
2.3%
Latest settlement · 16.5 days to cover
View all 122 metrics

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Strong Sell Momentum Very Weak Sentiment Neutral Fundamentals Strong Quant / Vol Very High
Market backdrop VIX 20.8 · elevated Equity put/call 0.60
Technical
price trend
Strong Sell
50 / 200-day cross No cross
Price vs 200-day avg −78%
below
Price vs 50-day avg −42%
below
RSI (14) 13
oversold
MACD trend Negative
52-week position 0%
near low
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Weak
1-month return −43%
trailing
6-month return −79%
trailing
YTD return −92%
this year
Relative strength −80%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $4 › 200d $10 — 200d above 50d
Institutional flow Accumulating
5 of 28 funds reported for Sep 30 · net +202 sh shares · +1 new
Insider flow Distributing
Net -$42.1K over 90 days · 100% sells
Short interest Falling
2.28% of shares out · ▼ -4.3% MoM · 16.5 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
28 holders — mid 3-yr range
Squeeze score 59
elevated · 0–100
Fundamentals
Strong
Revenue growth +42%
Y/Y
Gross margin 38%
contracting
EPS growth +45%
Y/Y
Free cash flow $-26.2M
Balance sheet $2.4M
net debt
Quant / Vol
risk profile
Very High
Volatility 102%
annualized · 1-yr
Max drawdown −94%
past year
ATR 11.4%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Latest guidance · from the Earnings Call filed Sep 2, 2026
Revenue · third quarter $68M – $73M
Prior guidance period ended · from the Earnings Call filed Dec 31, 2025
Revenue · first quarter of 2026 $50M – $55M

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Strong Sell
4 · 3 · 0
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−78% Bearish
Price vs 50-day avg
−42% Bearish
RSI (14)
13 Neutral
MACD trend
Negative Bearish
52-week position
0% Bearish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross) No cross
50d $4 › 200d $10 — 200d above 50d
Institutional flow Accumulating
5 of 28 funds reported for Sep 30 · net +202 sh shares · +1 new
Insider flow Distributing
Net -$42.1K over 90 days · 100% sells
Short interest Falling
2.28% of shares out · ▼ -4.3% MoM · 16.5 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
28 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $2 Now $2 · 0% Range high $39
vs 200-day avg -78% vs 50-day avg -42%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Consumer Electronics — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
ZEPP
Zepp Health Corp
this stock
$32.56M -91.8% +41.8% — 2.3%
AAPL
Apple Inc.
$4.82T +22.1% +15.9% 37.0 0.9%
SONY
Sony Group Corp
$152.16B -0.8% — — 0.0%
XIACF
Xiaomi Corporation
$91.36B -30.2% — — 0.5%
LPL
LG Display Co., Ltd.
$2.60B -38.2% — — 0.6%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
28
% held
15.9%
Reported
5 of 28
Top holder
MORGAN STANLEY
Held Float
View
Held by Funds
Fund positions
5
View
Short & Settlement
Short Interest Falling
Shares short
334.8K
Days to cover
16.5d
Change
-15.1K sh
View
Short Volume
Short vol %
53%
As of
Nov 3, 2026
Short Total
View
Fails to Deliver
FTD shares
500
Value
$2.0K
As of
Sep 30, 2026
View
Off-Exchange
Off-exchange %
47.5%
Week of
Sep 28, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net selling
Net (90d)
-$42.1K
Buyers / Sellers
0 / 1
Buyers Sellers
View
Financials
Financials
Revenue (FY)
$258.9M
Net income (FY)
$-40.1M
EPS diluted
$-0.16
View
Filings
SEC Filings
Latest
6-K
Filed
Sep 2, 2026
This year
4
View
Proposed Sales
Value
$86.6K
Shares
20.0K
Filed
Sep 23, 2026
View
Earnings & Events
Webcasts
Last webcast
Sep 2, 2026
View

Performance

5D 20D 120D MTD YTD
ZEPP -7.9% -43.2% -78.5% +0.9% -91.8%
SPY -2.0% -3.2% +1.6% -0.2% +10.6%
vs SPY -5.9% -40.0% -80.1% +1.1% -102.4%

Capital returns

Latest dividend
$0.40 / share · ex Mar 25, 2022
Paid (TTM)
$0.00 / share · 0 payouts
Dividend yield (TTM, derived)
— · no payout in the trailing year
Full dividend history

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1720446 CUSIP 98945L204 13F (30d) 4 filings 4 filers Visit website Investor relations